UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Joint EFLM-COLABIOCLI Recommendation for venous blood sampling

Clinical chemistry and laboratory medicine, 2018-11, Vol.56 (12), p.2015

2018

Volltextzugriff (PDF)

Impact of serum chitotriosidase activity on tuberculosis treatment response: single center study from Serbia

BMC pulmonary medicine, 2024-08, Vol.24 (1), p.1-6, Article 385

2024

Volltextzugriff (PDF)

Uncertainty of Measurement in Laboratory Medicine

Journal of medical biochemistry, 2018-07, Vol.37 (3), p.279-288

2018

Volltextzugriff (PDF)

Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA)

Clinical chemistry and laboratory medicine, 2013-08, Vol.51 (8), p.1585-1593

2013

Volltextzugriff (PDF)

Influence of lipid metabolism disorders on venous thrombosis risk

Journal of medical biochemistry, 2021-01, Vol.40 (3), p.245-251

2021

Volltextzugriff (PDF)

Verifying Sarcoidosis Activity: Chitotriosidase Versus ACE in Sarcoidosis – A Case-Control Study

Journal of medical biochemistry, 2016-10, Vol.35 (4), p.390-400

2016

Volltextzugriff (PDF)

Joint EFLM-COLABIOCLI recommendation for venous blood sampling - v 1.1, June 2018

Revista română de medicină de laborator, 2024-01, Vol.32 (1), p.9-32

2024

Volltextzugriff (PDF)

Immunoglobulin Heavy Chain Gene Rearrangements in Patients with Gaucher Disease

Journal of medical biochemistry, 2018-07, Vol.37 (3), p.307-312

2018

Volltextzugriff (PDF)

Serum Chitotriosidase: A Potential Marker of Sarcoidosis Activity

Chest, 2011-10, Vol.140 (4), p.927A-927A

2011

Volltextzugriff (PDF)

25(OH) D3 Vitamin Serum Levels Associated With Chronic Sarcoidosis

Chest, 2011-10, Vol.140 (4), p.617A-617A

2011

Volltextzugriff (PDF)

Soluble sPD-L1 and serum amyloid A1 as potential biomarkers for lung cancer

Journal of medical biochemistry, 2019-05, Vol.38 (3), p.332-341

2019

Volltextzugriff (PDF)

Biomarkers in Serbian patients with Gaucher disease

Clinical biochemistry, 2011-08, Vol.44 (12), p.950-954

2011

Volltextzugriff (PDF)

Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project

Clinica chimica acta, 2019-10, Vol.497, p.35-40

2019

Volltextzugriff (PDF)

Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project

Clinical chemistry and laboratory medicine, 2017-03, Vol.55 (3), p.348

2017

Volltextzugriff (PDF)

Peripheral neural response and sex hormones in type 1 Gaucher disease

Journal of medical biochemistry, 2020-01, Vol.39 (1), p.60-65

2020

Volltextzugriff (PDF)

Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group "Laboratory Error and Patient Safety" and EFLM Task and Finish Group "Performance specifications for the extra-analytical phases"

Clinical chemistry and laboratory medicine, 2017-08, Vol.55 (10), p.1478

2017

Volltextzugriff (PDF)

Harmonization of quality indicators in laboratory medicine. A preliminary consensus

Clinical chemistry and laboratory medicine, 2014-07, Vol.52 (7), p.951

2014

Volltextzugriff (PDF)

Compliance of blood sampling procedures with the CLSI H3-A6 guidelines: An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE)

Clinical chemistry and laboratory medicine, 2015-08, Vol.53 (9), p.1321

2015

Volltextzugriff (PDF)

The role of European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase in standardization and harmonization of the preanalytical phase in Europe

Annals of Clinical Biochemistry, 2016-09, Vol.53 (5), p.539-547

2016

Volltextzugriff (PDF)

Recomandarea comună EFLM-COLABIOCLI pentru recoltarea sângelui venos - v 1.1, iunie 2018: Joint EFLM-COLABIOCLI recommendation for venous blood sampling - v 1.1, June 2018

Revista română de medicină de laborator, 2024, Vol.32 (1), p.9

2024

Volltextzugriff (PDF)

Flow cytometric assessment of lymphocyte subsets in Gaucher type 1 patients

Blood cells, molecules, & diseases, 2014-12, Vol.53 (4), p.169-170

2014

Volltextzugriff (PDF)

Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease

Platelets (Edinburgh), 2012-03, Vol.23 (2), p.143-149

2012

Volltextzugriff (PDF)

Gammopathy and B lymphocyte clonality in patients with Gaucher type I disease

Blood cells, molecules, & diseases, 2013-03, Vol.50 (3), p.222-225

2013

Volltextzugriff (PDF)

Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy

Blood cells, molecules, & diseases, 2012-06, Vol.49 (1), p.58-59

2012

Volltextzugriff (PDF)

Joint EFLM-COLABIOCLI recommendation for venous blood sampling

Annales de biologie clinique (Paris), 2019-04, Vol.77 (2), p.131

2019

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Joint EFLM-COLABIOCLI Recommendation for venous blood sampling

Impact of serum chitotriosidase activity on tuberculosis treatment response: single center study from Serbia

Uncertainty of Measurement in Laboratory Medicine

Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA)

Influence of lipid metabolism disorders on venous thrombosis risk

Verifying Sarcoidosis Activity: Chitotriosidase Versus ACE in Sarcoidosis – A Case-Control Study

Joint EFLM-COLABIOCLI recommendation for venous blood sampling - v 1.1, June 2018

Immunoglobulin Heavy Chain Gene Rearrangements in Patients with Gaucher Disease

Serum Chitotriosidase: A Potential Marker of Sarcoidosis Activity

25(OH) D3 Vitamin Serum Levels Associated With Chronic Sarcoidosis

Soluble sPD-L1 and serum amyloid A1 as potential biomarkers for lung cancer

Biomarkers in Serbian patients with Gaucher disease

Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project

Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory Errors and Patient Safety" project

Peripheral neural response and sex hormones in type 1 Gaucher disease

Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group "Laboratory Error and Patient Safety" and EFLM Task and Finish Group "Performance specifications for the extra-analytical phases"

Harmonization of quality indicators in laboratory medicine. A preliminary consensus

Compliance of blood sampling procedures with the CLSI H3-A6 guidelines: An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE)

The role of European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase in standardization and harmonization of the preanalytical phase in Europe

Recomandarea comună EFLM-COLABIOCLI pentru recoltarea sângelui venos - v 1.1, iunie 2018: Joint EFLM-COLABIOCLI recommendation for venous blood sampling - v 1.1, June 2018

Flow cytometric assessment of lymphocyte subsets in Gaucher type 1 patients

Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease

Gammopathy and B lymphocyte clonality in patients with Gaucher type I disease

Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy

Joint EFLM-COLABIOCLI recommendation for venous blood sampling

Suchergebnisse filtern